Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

6.3%

1 terminated out of 16 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

19%

3 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

83% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (5)
Early P 1 (1)
P 1 (1)
P 3 (1)
P 4 (2)

Trial Status

Completed5
Recruiting4
Unknown3
Not Yet Recruiting1
Terminated1
Active Not Recruiting1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07453420Active Not Recruiting

Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.

NCT07359157Not ApplicableRecruiting

Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital

NCT07211750Not ApplicableRecruiting

Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT

NCT04031469Suspended

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

NCT06978452Recruiting

Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories

NCT06482762Early Phase 1RecruitingPrimary

Low-Intensity Focused Ultrasound of the Amygdala for Bipolar Disorder

NCT06748716Not ApplicableNot Yet RecruitingPrimary

Effect of Blue Light Blocking on Reducing Manic Symptoms in Bipolar Disorder

NCT06664138Phase 4Completed

Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment

NCT02184767Phase 1CompletedPrimary

Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication

NCT00666432Completed

Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes

NCT02189057Not ApplicableCompleted

A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression

NCT00300820Completed

Perspectives of Individuals With Bipolar Disorder and Siblings of Individuals With Bipolar Disorder; A Telephone Interview Study

NCT02133170Not ApplicableUnknownPrimary

"Mindfulness vs Psychoeducation in Bipolar Disorder"

NCT01131559Phase 3TerminatedPrimary

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

NCT00969930UnknownPrimary

Genetic Association Study Between Single Nucleotide Polymorphisms (SNPs) and Cognitive Performance in Young Bipolar Type I Patients: LICAVALGENE

NCT01047215Phase 4Unknown

Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine

Showing all 16 trials

Research Network

Activity Timeline